Skip to content

Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee

A Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02077647
Enrollment
20
Registered
2014-03-04
Start date
2014-03-31
Completion date
2019-07-31
Last updated
2020-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee, Osteonecrosis

Keywords

Knee osteoarthritis, knee osteonecrosis, osteotomy

Brief summary

The primary objective of this registry is to assess the functional outcome measured with the Knee Injury and Osteoarthritis Outcome Score (KOOS) for patients with medial unicompartmental osteoarthritis and osteonecrosis of the knee treated conservatively. The aim of the Focused Registry is to complete the data collection and enable a sound analysis for the Tomofix Small size study.

Detailed description

The aim of the Focused Registry is to complete the data collection and enable a sound analysis for the Tomofix Small size study. The incidence of knee osteoarthritis (OA) is higher in Japan than in other populations. Respective prevalences of 47.0 and 70.2% in men and women for Kellgren-Lawrence Grades 2-4 knee OA are reported in Japanese patients aged 60 years and over. First treatment options are pharmacological (i.e. NSAIDs) and non-pharmacological therapies (i.e. use of assistive devices, exercises, osteopathy, physical therapy), followed by injections of hyaluronic acid and other substances. If no such therapies are successful, surgical treatment options as unicompartmental knee replacement, total knee arthroplasty and high tibial osteotomy (HTO) are recognized. The discussion of which is the best therapy is still controversial. HTO may decrease the number of complications compared to total knee replacement or unicompartmental knee arthroplasty and leave the option for later replacement surgery. In this project, patients are included who would be surgically treated with HTO with Tomofix small based on the investigator's assessment but refuse to have surgical treatment. They will be treated conservatively and are investigated to serve as reference to an ongoing clinical study investigating invasive treatment modalities.

Interventions

None listed

Sponsors

AO Clinical Investigation and Publishing Documentation
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 40 years of age and older * Patients with OA Grade 1-4 (Kellgren-Lawrence) or osteonecrosis (ON) Stage 2-4 (according to the Koshino classification) * Indication for open wedge HTO with the TomoFix™ Small * No ligamental laxity * Able to understand and read country national language at an elementary level * Ability to understand the content of the patient information / informed consent form * Willingness and ability to participate in the registry according to the registry plan (RP) * Signed and dated IRB/EC-approved written informed consent

Exclusion criteria

* Femoro-tibial angle (FTA) \> 190° (standing view x-ray) * Flexion contracture \> 15° * Total knee replacement or unicompartmental knee on the contralateral side * Infections located between the middle of the femur and the ankle * Systemic bacterial infections * Severe osteoarthritis or surgery of the hip joint * Smoking of more than 20 cigarettes per day * Immunodeficiency or compromised host * Patients who have participated in any other device or drug related clinical trial within the previous month * ACL/PCL reconstruction of the same knee * Severe osteoarthritis of the ipsilateral ankle joint * HTO on the contralateral side * Major surgery on both knees (minor surgery as arthroscopic meniscectomy and synovectomy is allowed)

Design outcomes

Primary

MeasureTime frameDescription
Function of the knee24 monthsKnee Injury and Osteoarthritis Outcome Score (KOOS)

Secondary

MeasureTime frameDescription
Return to sport activities6 months, 12 months, 24 months
Utilizationup to hospital dischargeLength of hospital stay
Evaluation of degenerated and regenerated cartilageintraoperative and after 2 yearsICRS and Outerbridge / Koshino)
Radiological parameters6 months, 12 months, 24 monthsKellgren-Lawrence classification, joint space narrowing, tibial slope, tibia vara
Patient-evaluated function of the knee and quality of life6 months, 12 months, 24 monthsOxford-12-item knee score, WOMAC (as calculated from the KOOS)
Possibility and duration of the Japanese sitting style6 months, 12 months, 24 months
Health-related quality of life6 months, 12 months, 24 monthsShort Form-36 (SF-36)
Range of motion (ROM)6 months, 12 months, 24 months
Local and general pain6 months, 12 months, 24 monthsVisual Analogue Scale (VAS)
Complications6 months, 12 months, 24 monthsComplications due to injections, complications due to heat therapy, complications due to medication (NSAIDs)
Anatomical alignment6 months, 12 months, 24 monthsFemoro tibial angle (FTA)
Clinician-evaluated function of the knee6 months, 12 months, 24 monthsJapanese Orthopaedic Association (JOA) score

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026